England’s National Health Service (NHS) has stopped prescribing puberty blockers for children and young people with gender dysphoria or gender incongruence, saying there is “not enough evidence to support the safety or clinical effectiveness” of puberty-suppressing hormones.
NHS England said it made the decision, which was widely condemned by LGBTQ groups, after it “carefully considered” an evidence review it commissioned in 2020. It also reviewed evidence published since then, it said in a policy document published Tuesday.
Read Full Article »